EZH2 and head and neck squamous cell carcinoma: In HNSCC cell lines, significant reductions in H3K27me3 (EZH2 substrate) were seen on western blots in response to epigenetic inhibitors, with differences seen between HPV+ and HPV- cells (Fig. 2).